Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Trump’s renewed push to revive the Rush Hour franchise is drawing investor attention. Analysts say licensing, streami...
New disclosures show trump’s ‘unusual’ brokerage account trading around policy headlines, shifting from tech giants t...
Ethereum faces renewed selling pressure as ether trader sentiment falls to its lowest level in three years. The signa...
Bitcoin stabilizes in the mid-30s thousands as ETF demand persists, with Ethereum and XRP offering measured upside on...
Ethereum flirts with a critical level as it trades around the $2,100 mark. A breakdown of $1,800 could accelerate los...
Oil prices edge up near the mid-$90s on June 1, 2026, as traders weigh supply risks and summer demand. Brent sits aro...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...
Google Gemini AI has nudged XRP back into the spotlight with a bold price target for 2026. This report breaks down wh...
SpaceX hits the public markets with a high-profile IPO, but the spacex president warning investors message underscore...
New on-chain data indicate a quieting crypto market, with trading volume retreating to yearly lows and a record-high ...
A WSJ investigation claims polymarket paid creators to stage fake winning bets on dummy sites, highlighting risks aro...